EMX International

Our diagnostic laser breathalyzer is for unprecedented early detection of lung cancer, breast cancer and other diseases, prior to revelation by CT or MRI.

Biotechnology

We are an emerging leader in sensor technologies, implementing our patented diagnostic laser breathalyzer in the healthcare marketplace: Detection of lung and breast cancer 8 to 10 years before CT or MRI, early detection of Alzheimer's and Parkinson's disease, unprecedented accuracy, inexpensive, non-invasive, real-time results, proprietary technology, numerous patents issued, renowned staff, new revenue for Doctors, Hospitals, Clinics.

Basics

  • Number of Employees
  • Stage
    Prototype (MVP) Ready
  • Founded
    1970
  • Primary Industry
    Biotechnology

Description

We are an emerging leader in sensor technologies, implementing our patented diagnostic laser breathalyzer in the healthcare marketplace: Detection of lung and breast cancer 8 to 10 years before CT or MRI, early detection of Alzheimer’s and Parkinson’s disease, unprecedented accuracy, inexpensive, non-invasive, real-time results, proprietary technology, numerous patents issued, renowned staff, new revenue for Doctors, Hospitals, Clinics.